Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,375,034
+$339,074 QoQ
Shares Held
29,039
+0.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.34%
of 13F equity value
Holder Rank
#1,306
of 4,676 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026American Trust holds $20,823,022 across 9 Drug Manufacturers - General names. JNJ ranks #1 (35.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
29,039 | $7,375,034 | |
| 2 | LLY |
ELI LILLY & Co
|
5,900 | $7,076,637 | |
| 3 | ABBV |
AbbVie Inc.
|
18,211 | $4,582,616 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,865 | $496,652 | |
| 5 | PFE |
Pfizer Inc
|
11,643 | $280,363 | |
| 6 | AMGN |
Amgen Inc
|
771 | $279,194 | |
| 7 | NVS |
Novartis AG
|
1,745 | $273,476 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,978 | $249,900 |
All Filings in JNJ
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,375,034 | 29,039 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,035,960 | 28,784 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $6,955,796 | 33,611 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,235,674 | 33,630 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $5,013,713 | 32,823 | Shares | Sole | 2025-09-03 | |
| 2025-03-31 | $5,134,074 | 30,958 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $4,702,174 | 32,514 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $4,983,345 | 30,750 | Shares | Sole | 2024-11-29 | |
| 2024-06-30 | $5,179,325 | 35,436 | Shares | Sole | 2024-09-12 | |
| 2024-03-31 | $5,969,141 | 37,734 | Shares | Sole | 2024-06-11 | |
| 2023-12-31 | $6,877,907 | 43,881 | Shares | Sole | 2024-02-21 | |
| 2023-09-30 | $6,640,400 | 42,635 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $7,250,768 | 43,806 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,843,560 | 44,152 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $7,140,545 | 40,422 | Shares | Defined | 2023-02-16 | |
| 2022-09-30 | $6,653,161 | 40,727 | Shares | Defined | 2022-12-02 | |
| 2022-06-30 | $7,983,689 | 44,976 | Shares | Sole | 2022-10-03 | |
| 2022-03-31 | $9,208,870 | 51,960 | Shares | Sole | 2022-06-08 | |
| 2021-12-31 | $7,092,048 | 41,457 | Shares | Defined | 2022-03-17 | |
| No filing history on record for this holder in this stock. | ||||||